[Tumoral secretion markers: something more than clinical indicators].
Ruibal Morell
A
A
D015703:Antigens, CD / Q000502:physiology; D000943:Antigens, Differentiation / Q000502:physiology; D000951:Antigens, Neoplasm / Q000502:physiology; D014408:Biomarkers, Tumor / Q000502:physiology*; D018395:CA-19-9 Antigen / Q000502:physiology; D002272:Carcinoembryonic Antigen / Q000502:physiology; D015815:Cell Adhesion Molecules; D006801:Humans; D007610:Kallikreins / Q000502:physiology; D053539:Keratin-19; D007633:Keratins; D009363:Neoplasm Proteins / Q000502:physiology; D009369:Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D015843:Serpins; D000509:alpha-Fetoproteins / Q000502:physiology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; C069847:CD66 antigens; D002272:Carcinoembryonic Antigen; D015815:Cell Adhesion Molecules; D053539:Keratin-19; D009363:Neoplasm Proteins; D015843:Serpins; D000509:alpha-Fetoproteins; C102012:antigen CYFRA21.1; C051072:squamous cell carcinoma-related antigen; D007633:Keratins; D007610:Kallikreins